RenovoRx, Inc. (RNXT)
1.12
-0.03
(-2.61%)
USD |
NASDAQ |
Oct 14, 16:00
1.15
+0.03
(+2.68%)
Pre-Market: 09:06
RenovoRx Total Long Term Debt (Quarterly) : 0.259M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.259M |
| March 31, 2026 | 0.078M |
| December 31, 2025 | 0.107M |
| September 30, 2025 | 0.134M |
| June 30, 2025 | 0.161M |
| March 31, 2025 | 0.186M |
| December 31, 2024 | 0.212M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 12.45M |
| March 31, 2021 | 12.45M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Enanta Pharmaceuticals, Inc. | 178.13M |
| Travere Therapeutics, Inc. | 610.74M |
| REGENXBIO, Inc. | 243.11M |
| Krystal Biotech, Inc. | 7.045M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |